Chen Yi-Chun, Wu Yih-Ru, Mesri Mina, Chen Chiung-Mei
From the Department of Neurology, Chang Gung Memorial Hospital Linkou Medical Center and College of Medicine, Chang-Gung University, Taoyuan, Taiwan (Y-CC, Y-RW, C-MC); and Medicine and Surgery MBChB, School of Medicine, University of Liverpool, Liverpool, United Kingdom (MM).
Medicine (Baltimore). 2016 Feb;95(5):e2672. doi: 10.1097/MD.0000000000002672.
Matrix metalloproteinases (MMPs) function in the degradation of extracellular matrix and are considered to play a role in the pathogenesis of neurodegenerative diseases including Parkinson disease (PD). MMPs activities are modulated by tissue inhibitors of metalloproteinases (TIMPs). This study examined whether the genetic polymorphisms of MMP-3, gelatinase (MMP-2 and MMP-9), TIMP-2, and TIMP-1 were associated with PD in Taiwan.A total of 359 PD patients and 332 controls were enrolled. The candidate genetic variants included MMP-2 rs2285053 (-735 C > T), MMP-3 rs3025058 (-1171 5A > 6A), MMP-9 rs3918241 (-1831 T > A), rs17576 (G > A, R279Q), and rs3787268 (G > A, intron), TIMP-1 rs4898 (T > C, F124F), and TIMP-2 rs7503607 (-269 G > T). Associations were tested by logistic regression, adjusted with gender and age at onset.Minor allele frequency of TIMP-1 rs4898 (36.0%) was significantly lower in the male PD patients than in the male controls (51.2%) (χ test, P = 0.004). When adjusted with gender and age at onset, MMP-9 rs17576 AA genotype was associated with PD susceptibility in a recessive fashion (odds ratios [OR] = 2.28, 95% confidence intervals [95% CI] = 1.12-4.62, P = 0.02). In males, TIMP-1 rs4898 C allele was associated with a protective effect on PD (OR = 0.75, 95% CI = 0.60-0.94, P = 0.014). We did not find association between the examined genetic variants of MMP-2, MMP-3, and TIMP-2 and PD susceptibility.This is the first study that demonstrated a protective effect of TIMP-1 rs4898 C allele on male PD and a modest association of MMP-9 rs17576 AA genotype with PD susceptibility in the Taiwan population. Further replication is needed for confirmation.
基质金属蛋白酶(MMPs)在细胞外基质降解中发挥作用,并被认为在包括帕金森病(PD)在内的神经退行性疾病发病机制中起作用。MMPs的活性受金属蛋白酶组织抑制剂(TIMPs)调节。本研究调查了MMP-3、明胶酶(MMP-2和MMP-9)、TIMP-2和TIMP-1的基因多态性是否与台湾地区的PD相关。共纳入359例PD患者和332例对照。候选基因变异包括MMP-2 rs2285053(-735 C>T)、MMP-3 rs3025058(-1171 5A>6A)、MMP-9 rs3918241(-1831 T>A)、rs17576(G>A,R279Q)和rs3787268(G>A,内含子)、TIMP-1 rs4898(T>C,F124F)以及TIMP-2 rs7503607(-269 G>T)。通过逻辑回归检验关联性,并根据性别和发病年龄进行校正。TIMP-1 rs4898的次要等位基因频率在男性PD患者中(36.0%)显著低于男性对照(51.2%)(χ检验,P = 0.004)。在根据性别和发病年龄校正后,MMP-9 rs17576 AA基因型以隐性方式与PD易感性相关(比值比[OR]=2.28,95%置信区间[95%CI]=1.12 - 4.62,P = 0.02)。在男性中,TIMP-1 rs4898 C等位基因对PD具有保护作用(OR = 0.75,95%CI = 0.60 - 0.94,P = 0.014)。我们未发现MMP-2、MMP-3和TIMP-2的检测基因变异与PD易感性之间存在关联。这是第一项证明TIMP-1 rs4898 C等位基因对男性PD具有保护作用以及MMP-9 rs17576 AA基因型与台湾人群PD易感性存在适度关联的研究。需要进一步重复研究以进行确认。